greeksoup/ stock research

Sabra Health Care REIT (SBRA) Q1 FY2023 earnings: revenue $161 million, down 1.1% on the year

Sabra Health Care REIT, Inc. (SBRA) reported revenue of $161 million for Q1 FY2023, the quarter ended 31 March 2023, down 1.1% on the same quarter a year earlier. Net income was -$9 million, and diluted earnings per share $-0.04. The figures are the company's own, from the 10-Q it filed with the SEC on 3 May 2023.

Revenue
$161 million
-1.1% on the year · -2.2% on the quarter
Q2 FY2021Q1 FY2023
Operating margin
n/a
Q2 FY2021Q1 FY2023
Net income
-$9 million
Q2 FY2021Q1 FY2023
Diluted EPS
-$0.04
Q2 FY2021Q1 FY2023

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ1 FY2023Q4 FY2022Q1 FY2022On the quarterOn the yearLast 8 quarters
Revenue161165163-2.2%-1.1%
Interest expense28.527.925.0+2.3%+14.3%
Pre-tax income-7.93.543.7
Income tax0.70.10.3+487.1%+156.3%
Effective tax raten/a3.5%0.7%
Net income-9.5-84.940.6
Net margin-5.9%-51.5%24.9%
Diluted EPS-$0.04-$0.37$0.18
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2023Q4 FY2022Q1 FY2022On the quarterOn the yearLast 8 quarters
Operating cash flow68.367.663.1+1.0%+8.2%
Cash from investing113-31.2-37.2
Cash from financing-196-13.5-113
Depreciation and amortisation52.849.945.3+5.8%+16.7%
Share-based compensation2.22.12.5+6.9%-9.2%
Dividends paid69.469.369.3+0.1%+0.1%
Dividend per share$0.30n/a$0.300.0%
Diluted shares, weighted231m231m232m+0.1%-0.2%
Shares outstanding at period end231m231m231m+0.1%+0.1%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2023Q4 FY2022Q1 FY2022On the quarterOn the yearLast 8 quarters
Shareholders' equity2,9763,0563,362-2.6%-11.5%
Debt2,3972,5072,358-4.4%+1.7%
Other liabilities183185166-0.6%+10.6%
Total liabilities and equity5,5565,7485,885-3.3%-5.6%
Intangible assets39.440.152.9-1.9%-25.5%
Cash and equivalents33.549.324.8-32.0%+35.0%
Other assets5,4835,6585,807-3.1%-5.6%
Total assets5,5565,7485,885-3.3%-5.6%

Questions

What was Sabra Health Care REIT's revenue in Q1 FY2023?

Sabra Health Care REIT (SBRA) reported revenue of $161 million for Q1 FY2023, the quarter ended 31 March 2023, down 1.1% on the same quarter a year earlier.

How much did Sabra Health Care REIT earn in Q1 FY2023?

Net loss for Q1 FY2023 was $9 million, and the diluted loss per share $0.04.

When did Sabra Health Care REIT report Q1 FY2023 results?

Sabra Health Care REIT filed its 10-Q for the quarter ended 31 March 2023 with the SEC on 3 May 2023.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue136163156141165161161162163167176178182184189190212222236250
Interest expense25.725.025.527.127.928.528.328.227.928.429.329.528.127.127.528.928.928.429.829.2
Pre-tax income-10.643.719.6-45.13.5-7.922.2-14.018.427.324.329.347.240.565.221.726.039.4-26.826.4
Tax raten/a1%1%n/a4%n/a1%n/a3%2%2%-1%1%1%1%2%2%1%n/a0%
Net income-24.440.616.8-50.1-84.9-9.521.2-15.117.226.324.029.846.740.365.522.527.240.9-25.228.6
Net margin-18%25%11%-36%-51%-6%13%-9%10%16%14%17%26%22%35%12%13%18%-11%11%
Diluted EPS-$0.12$0.18$0.07-$0.22-$0.37-$0.04$0.09-$0.07$0.07$0.11$0.10$0.13$0.19$0.17$0.27$0.09$0.11$0.16-$0.10$0.11
Operating cash flow97.963.176.610867.668.370.383.278.752.880.197.780.080.381.0100.087.498.485.8129
Dividends paid68.669.369.369.369.369.469.469.469.469.469.570.371.071.471.471.974.875.775.776.6
Shares outstanding230m231m231m231m231m231m231m231m231m231m234m237m238m238m240m249m252m252m255m262m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 March 2023, filed 3 May 2023: the filing.